Tomás Ibarra

Gene editing

Tessaly sues two startups, alleging theft of gene editing trade secrets

The complaint says a former scientist took confidential designs and helped launch a competing rare disease program. Both defendants deny the claims.

Sept. 21, 2026·Gene Therapy

Marrow Peak falls on four-year data for its Huntington's gene therapy

Disease progression slowed by 41% compared with a matched external group, down from 60% at the three-year mark.

Sept. 19, 2026·Gene Therapy

Immune reset

An off-the-shelf cell therapy shows early promise against lupus

Nine of eleven patients in a first trial were in remission without medication six months after a single infusion.

Sept. 12, 2026·Gene Therapy